177 related articles for article (PubMed ID: 15992889)
1. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats.
Khera M; Somogyi GT; Salas NA; Kiss S; Boone TB; Smith CP
Urology; 2005 Jul; 66(1):208-12. PubMed ID: 15992889
[TBL] [Abstract][Full Text] [Related]
2. The effects of botulinum-A toxin on bladder function and histology in spinal cord injured rats: is there any difference between early and late application?
Temeltas G; Tikiz C; Dagci T; Tuglu I; Yavasoglu A
J Urol; 2005 Dec; 174(6):2393-6. PubMed ID: 16280854
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury.
Khera M; Somogyi GT; Kiss S; Boone TB; Smith CP
Neurochem Int; 2004 Dec; 45(7):987-93. PubMed ID: 15337297
[TBL] [Abstract][Full Text] [Related]
4. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
Atiemo H; Wynes J; Chuo J; Nipkow L; Sklar GN; Chai TC
Urology; 2005 Mar; 65(3):622-6. PubMed ID: 15780404
[TBL] [Abstract][Full Text] [Related]
5. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
Munoz A; Somogyi GT; Boone TB; Smith CP
Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravesical capsaicin and resiniferatoxin on distension-induced bladder contraction in conscious rats with and without chronic spinal cord injury.
Komiyama I; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE
J Urol; 1999 Jan; 161(1):314-9. PubMed ID: 10037430
[TBL] [Abstract][Full Text] [Related]
7. Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.
Smith CP; Vemulakonda VM; Kiss S; Boone TB; Somogyi GT
Neurochem Int; 2005 Sep; 47(4):291-7. PubMed ID: 15970360
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation.
Vemulakonda VM; Somogyi GT; Kiss S; Salas NA; Boone TB; Smith CP
J Urol; 2005 Feb; 173(2):621-4. PubMed ID: 15643276
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.
Smith CP; Gangitano DA; Munoz A; Salas NA; Boone TB; Aoki KR; Francis J; Somogyi GT
Neurochem Int; 2008 May; 52(6):1068-75. PubMed ID: 18187233
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
Abdel-Gawad M; Dion SB; Elhilali MM
J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.
Lucioni A; Bales GT; Lotan TL; McGehee DS; Cook SP; Rapp DE
BJU Int; 2008 Feb; 101(3):366-70. PubMed ID: 18184328
[TBL] [Abstract][Full Text] [Related]
12. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
13. The role of capsaicin-sensitive afferent fibers in the lower urinary tract dysfunction induced by chronic spinal cord injury in rats.
Cheng CL; de Groat WC
Exp Neurol; 2004 Jun; 187(2):445-54. PubMed ID: 15144870
[TBL] [Abstract][Full Text] [Related]
14. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL
Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237
[TBL] [Abstract][Full Text] [Related]
15. The effect of intravesical electrical stimulation on bladder function and synaptic neurotransmission in the rat spinal cord after spinal cord injury.
Hong CH; Lee HY; Jin MH; Noh JY; Lee BH; Han SW
BJU Int; 2009 Apr; 103(8):1136-41. PubMed ID: 19021629
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic role of oral L-arginine on histological and contractile changes in a rat chronic bladder injury model.
Ozgür A; Onol FF; Ercan F; Tarcan T
Urol Int; 2008; 81(3):347-52. PubMed ID: 18931556
[TBL] [Abstract][Full Text] [Related]
17. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
Eur Urol; 2009 Jul; 56(1):159-66. PubMed ID: 18514386
[TBL] [Abstract][Full Text] [Related]
18. The effects of Glivec on the urinary bladder excitation of rats with suprasacral or sacral spinal cord transection.
Deng J; Zhang Y; Wang L; Zhao J; Song B; Li L
J Surg Res; 2013 Aug; 183(2):598-605. PubMed ID: 23608618
[TBL] [Abstract][Full Text] [Related]
19. Expressions of voltage-gated K+ channel 2.1 and 2.2 in rat bladder with detrusor hyperreflexia.
Gan XG; An RH; Bai YF; Zong DB
Chin Med J (Engl); 2008 Aug; 121(16):1574-7. PubMed ID: 18982871
[TBL] [Abstract][Full Text] [Related]
20. Passive biaxial mechanical properties of the rat bladder wall after spinal cord injury.
Gloeckner DC; Sacks MS; Fraser MO; Somogyi GT; de Groat WC; Chancellor MB
J Urol; 2002 May; 167(5):2247-52. PubMed ID: 11956487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]